Contralateral prophylactic mastectomy: are we overtreating patients?

被引：5

作者：

Burke, Erin E. ^{[1
]}

Portschy, Pamela R. ^{[1
]}

Tuttle, Todd M. ^{[2
]}

机构：

[1] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Minneapolis, MN 55455 USA

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2014年 / 14卷 / 05期

关键词：

contralateral; breast; risk perceptions; overtreatment; prophylactic; BREAST-CANCER PATIENTS; INCREASING RATES; WOMEN; TAMOXIFEN; RISK; SATISFACTION; PREDICTORS; EFFICACY; DECISION; HISTORY;

D O I：

10.1586/14737140.2014.883284

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with unilateral breast cancer are at increased risk for developing cancer in the contralateral breast. As a result, some patients choose contralateral prophylactic mastectomy (CPM) to prevent cancer in the contralateral breast. Several studies have reported that the CPM rates have markedly increased in recent years in the United States. In this article, we will discuss recent CPM trends, potential reasons patients choose CPM, outcomes after CPM, and alternative strategies for managing the increased risk of contralateral breast cancer among survivors of unilateral breast cancer. In addition, we will try to determine if women undergoing CPM are adequately informed about their decision.

引用

页码：491 / 494

页数：4

共 29 条

[1] Perceptions of Contralateral Breast Cancer: An Overestimation of Risk [J].

Abbott, Andrea ;

Rueth, Natasha ;

Pappas-Varco, Susan ;

Kuntz, Karen ;

Kerr, Elizabeth ;

Tuttle, Todd .

ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (11) :3129-3136

[2] Positive, negative, and disparate - Women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy [J].

Altschuler, Andrea ;

Nekhlyudov, Larissa ;

Rolnick, Sharon J. ;

Greene, Sarah M. ;

Elmore, Joann G. ;

West, Carmen N. ;

Herrinton, Lisa J. ;

Harris, Emily L. ;

Fletcher, Suzanne W. ;

Emmons, Karen M. ;

Geiger, Ann M. .

BREAST JOURNAL, 2008, 14 (01) :25-32

[3]

[Anonymous], 1998, LANCET, V351, P1451, DOI DOI 10.1016/S0140-6736(97)11423-4

[4]

Baum M, 2002, LANCET, V359, P2131

[5] Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients [J].

Bedrosian, Isabelle ;

Hu, Chung-Yuan ;

Chang, George J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (06) :401-409

[6] Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer [J].

Boughey, Judy C. ;

Hoskin, Tanya L. ;

Degnim, Amy C. ;

Sellers, Thomas A. ;

Johnson, Joanne L. ;

Kasner, Melanie J. ;

Hartmann, Lynn C. ;

Frost, Marlene H. .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (10) :2702-2709

[7] Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials [J].

Davies, C. ;

Godwin, J. ;

Gray, R. ;

Clarke, M. ;

Darby, S. ;

McGale, P. ;

Wang, Y. C. ;

Peto, R. ;

Pan, H. C. ;

Cutter, D. ;

Taylor, C. ;

Ingle, J. .

LANCET, 2011, 378 (9793) :771-784

[8] NEW PERSPECTIVE ON CANCER OF THE CONTRALATERAL BREAST - A MARKER FOR ASSESSING TAMOXIFEN AS A PREVENTIVE AGENT [J].

FISHER, B ;

REDMOND, C .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (18) :1278-1280

[9] Satisfaction after contralateral prophylactic mastectomy: The significance of mastectomy type, reconstructive complications, and body appearance [J].

Frost, MH ;

Slezak, JM ;

Tran, NV ;

Williams, CI ;

Johnson, JL ;

Woods, JE ;

Petty, PM ;

Donohue, JH ;

Grant, CS ;

Sloan, JA ;

Sellers, TA ;

Hartmann, LC .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7849-7856

[10] Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study [J].

Gao, X ;

Fisher, SG ;

Emami, B .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :1038-1045

← 1 2 3 →